Established in 2016, the WashU Medicine RVCL-S Research Center is leading an effort to coordinate global research on retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S), provide comprehensive and multidisciplinary patient care and initiate clinical studies and drug trials.